Literature DB >> 7620169

True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases.

J D Hoyer1, C W Ross, C Y Li, T E Witzig, R D Gascoyne, G W Dewald, C A Hanson.   

Abstract

We studied 25 T-cell chronic lymphocytic leukemia (T-CLL) cases collected over a 15-year period. Immunophenotypic analysis was performed in each case; 12 cases were evaluated by cytogenetics, and gene rearrangement studies were performed in 14 cases. The median age was 57 years with a male predominance (M:F, 15:10). The median presenting lymphocyte count was 36.3 x 10(9)/L (range, 3.9 to 438 x 10(9)/L). Fourteen patients (56%) had shotty adenopathy and ten (40%) had mild-to-moderate splenomegaly at presentation; four (16%) had erythematous skin lesions. The lymphocytes were predominantly small; some cases had a minor component of medium-sized cells (< 10%). The nuclear: cytoplasmic ratios were uniformly high with round to oval nuclei; however, a wide spectrum of nuclear outlines could be found, ranging from minimally to markedly convoluted. Nucleoli were either absent or small and inconspicuous. These lymphocytes did not have the morphology of prolymphocytes and did not contain cytoplasmic granules. Bone marrow infiltration was generally in an interstitial pattern; the degree of involvement ranged from 15% to 90%. Immunophenotyping showed that the lymphocytes were mature T-cells with a predominant CD4+ immunophenotype. Three cases displayed a CD8+ immunophenotype. The patients were treated with a variety of chemotherapeutic regimens with only a minimal response observed in two of 20 patients. We conclude that T-CLL is an uncommon chronic lymphoproliferative disorder (CLPD) that can be morphologically similar to B-CLL, is distinct from T-prolymphocytic leukemia, and has an aggressive clinical course that is refractory to therapy. It may also be difficult to distinguish T-CLL from other T-CLPD, especially the leukemic phase of peripheral T-cell lymphoma and some cases of Sézary syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7620169

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.

Authors:  A Miyata; K Kojima; T Yoshino; S Fujii; K Shinagawa; K Ichimura
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  T-cell prolymphocytic leukemia in Japan: is it a variant?

Authors:  Junichi Kameoka; Naoto Takahashi; Hideyoshi Noji; Kazunori Murai; Katsushi Tajima; Yoshihiro Kameoka; Shinji Sato; Tsutomu Shichishima; Yoji Ishida; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2012-04-24       Impact factor: 2.490

3.  Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Authors:  Ke Lan; Masanao Murakami; Tathagata Choudhuri; Donald E Tsai; Stephen J Schuster; Mariusz A Wasik; Erle S Robertson
Journal:  J Clin Virol       Date:  2008-09-14       Impact factor: 3.168

4.  TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.

Authors:  Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Takeki Mitsui; Hiromi Koiso; Yoshitora Kim; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Takahiro Jimbo; Kayoko Murayama; Tohru Sakura; Hirokazu Murakami; Masamitsu Karasawa; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2011-12-23       Impact factor: 2.490

5.  Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab.

Authors:  Naoko Watanabe; Takayuki Takahashi; Naoshi Sugimoto; Yasuhiro Tanaka; Masayuki Kurata; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Kohji Nasu
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

6.  Lectin-mediated microfluidic capture and release of leukemic lymphocytes from whole blood.

Authors:  Dwayne A L Vickers; Marina Hincapie; William S Hancock; Shashi K Murthy
Journal:  Biomed Microdevices       Date:  2011-06       Impact factor: 2.838

Review 7.  Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.

Authors:  Aude Collignon; Anne Wanquet; Elsa Maitre; Edouard Cornet; Xavier Troussard; Thérèse Aurran-Schleinitz
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

8.  A case of T cell prolymphocytic leukemia involving blast transformation.

Authors:  Kunimoto Ichikawa; Masaaki Noguchi; Hidenori Imai; Yasunobu Sekiguchi; Mutsumi Wakabayashi; Tomohiro Sawada; Norio Komatsu
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

Review 9.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

10.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.